Deferoxamine inhibition of malaria is independent of host iron status.
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
The mechanism whereby deferoxamine (DF) inhibits the growth of malaria parasites was studied in rats infected with Plasmodium berghei. Peak parasitemia was 32.6% (day 14) in untreated controls and 0.15% (day 7) in rats receiving 0.33 mg/g in 8 hourly DF injections, subcutaneously. DF inhibition of parasite growth was achieved without any reduction in transferrin saturation or hemoglobin synthesis and with only a partial (56%) depletion of hepatic iron stores. Dietary iron depletion resulted in anemia (hematocrit 25 vs. 46%), microcytosis (MCV 54 vs. 60 fl), and reduced transferrin saturation (17 vs. 96%) without any effect on infection (peak parasitemia 30 vs. 36%). Similarly, parenteral iron loading with ferric citrate over 10 d (75 mg iron/kg) failed to aggravate infection. In a search for evidence of direct interaction between DF and parasitized erythrocytes, gel filtration and ultrafiltration was performed on hemolysates obtained from in vivo 59Fe-labeled parasitized erythrocytes. This showed that 1.1-1.9% of the intracellular radioiron was located in a chelatable, labile iron pool. Incubation of intact cells with 0-500 microM DF resulted in a proportional increase in intracellular iron chelation, and the chelation of all available labile intracellular iron was completed within 6 h. These observations indicate that the severity of P. berghei infection in rats and its in vivo suppression by DF are independent of host iron status and suggest that DF inhibition of malaria involves intracellular chelation of a labile iron pool in parasitized erythrocytes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gutteridge, J. M. C. (1986) · FEBS Letters · doi:10.1016/0014-5793(86)80626-3 · Cited by 629
Weinberg, E. D. (1974) · Science · doi:10.1126/science.184.4140.952 · Cited by 579
The adverse effect of iron repletion on the course of certain infections.
Murray, M. J., Murray, A. B., Murray, M. B., & Murray, C. J. (1978) · BMJ · doi:10.1136/bmj.2.6145.1113 · Cited by 453
Kochan, I. (1973) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-642-65502-9_1 · Cited by 237
Oppenheimer, S. J., Gibson, F. D., Macfarlane, S. B., Moody, J. B., Harrison, C., Spencer, A., & Bunari, O. (1986) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/0035-9203(86)90154-9 · Cited by 205
Plasmodium falciparum takes up iron from transferrin
Pollack, S., & Fleming, J. (1984) · British Journal of Haematology · doi:10.1111/j.1365-2141.1984.tb06087.x · Cited by 66
Cited by
Oxidative stress in malaria parasite-infected erythrocytes: host–parasite interactions
Becker, K., Tilley, L., Vennerstrom, J. L., Roberts, D., Rogerson, S., & Ginsburg, H. (2004) · International Journal for Parasitology · doi:10.1016/j.ijpara.2003.09.011 · Cited by 652
Drug Antioxidant Effects: A Basis for Drug Selection?
Halliwell, B. (1991) · Drugs · doi:10.2165/00003495-199142040-00003 · Cited by 353
Newton, C. (1998) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(98)00008-4 · Cited by 348
Iron-dependent free radical generation from the antimalarial agent artemisinin (qinghaosu)
Meshnick, S. R., Yang, Y. Z., Lima, V, Kuypers, F., Kamchonwongpaisan, S., & Yuthavong, Y. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.5.1108 · Cited by 327
“The antimalarial activities of iron chelators appear to be dependent on their penetration into the parasite (15, 22, 40).”
BackgroundByrd, T. F., & Horwitz, M. A. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114038 · Cited by 320
Iron Deficiency Protects Against Severe Plasmodium falciparum Malaria and Death in Young Children
Gwamaka, M., Kurtis, J. D., Sorensen, B. E., Holte, S., Morrison, R., Mutabingwa, T. K., Fried, M., & Duffy, P. E. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis010 · Cited by 197
Iron, anemia and hepcidin in malaria
Spottiswoode, N., Duffy, P. E., & Drakesmith, H. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00125 · Cited by 127
Byrd, T. F., & Horwitz, M. A. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115301 · Cited by 120
Iron Chelation Therapy for Malaria
Mabeza, G. F., Loyevsky, M., Gordeuk, V. R., & Weiss, G. (1999) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(98)00037-0 · Cited by 111
“berghei in rats (Hershko and Peto, 1988).”
BackgroundInfluentialOxygen‐based free radical generation by ferrous ions and deferoxamine
Klebanoff, S. J., Waltersdorph, A. M., Michel, B. R., & Rosen, H. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)47178-0 · Cited by 101
Fritsche, G., Larcher, C., Schennach, H., & Weiss, G. (2001) · The Journal of Infectious Diseases · doi:10.1086/319860 · Cited by 84
“Previous data indicate that the growth-limiting effect of DFO on parasites cannot be attributed exclusively to restriction of iron availability to the pathogen [6], and it has been suggested that this beneficial effect of DFO could be due to immune”
BackgroundHershko, C., Gordeuk, V. R., Brittenham, G. M., Thuma, P. E., Theanacho, E. N., Spira, D. T., Hider, R. C., & Peto, T. E. A. (1992) · Journal of Inorganic Biochemistry · doi:10.1016/0162-0134(92)84072-u · Cited by 57
Self-citationThe Treatment of Malaria with Iron Chelators
Hider, R. C., & Liu, Z. (1997) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1997.tb06162.x · Cited by 26
Azcárate, I. G., Sánchez-Jaut, S., Marín-García, P., Linares, M., Pérez-Benavente, S., García-Sánchez, M., Uceda, J., Kamali, A. N., Morán-Jiménez, M.-J., Puyet, A., et al. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.09.027 · Cited by 12
Metadata
- Authors
- Hershko, C., & Peto, T. E.
- Venue
- The Journal of experimental medicine
- Publisher
- Rockefeller University Press
- Published
- 1988-07-01
- Volume
- 168
- Issue
- 1
- Pages
- 375-387
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2148053140
- Cited by
- 124
- References
- 6
- FWCI
- 8.68
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.